ORIC Pharmaceuticals Inc

NASDAQ:ORIC   4:00:00 PM EDT
3.59
-0.16 (-4.27%)
4:17:03 PM EDT: $3.45 -0.14 (-3.90%)
Earnings Announcements

Oric Pharmaceuticals Reports Third Quarter 2022 Financial Results

Published: 11/07/2022 22:34 GMT
ORIC Pharmaceuticals Inc (ORIC) - Oric Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Update.
Oric Pharmaceuticals Inc - Qtrly Loss per Share $0.63.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.56

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.61

More details on our Analysts Page.